Klinik çalışmalarda son durum

Tuesday, July 09, 2013 Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) Type: Interventional Phase: II Recruiting?: Currently Recruiting Sponsor: University of Washington

Tuesday, July 09, 2013 Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis Type: Interventional Phase: II Recruiting?: Currently Recruiting Sponsor: GlaxoSmithKline

Wednesday, July 03, 2013 Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) Type: Interventional Phase: IIB Recruiting?: Currently Recruiting Sponsor: Cytokinetics

Tuesday, July 02, 2013 A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy Type: Interventional Phase: I Recruiting?: Currently Recruiting Sponsor: Mayo Clinic

Wednesday, June 26, 2013 Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) Type: Interventional Phase: II Recruiting?: Not Yet Recruiting Sponsor: Emory University